Terms: = Ovarian cancer AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb AND Diagnosis
6 results:
1. LncRNA
Wang J; Han Y; Zhang T; Li J; Xu B
Front Biosci (Landmark Ed); 2023 Oct; 28(10):270. PubMed ID: 37919051
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathologic significance and race-specific prognostic association of myb overexpression in ovarian cancer.
Miree O; Srivastava SK; Khan MA; Sameeta F; Acharya S; Ndetan H; Singh KP; Hertweck KL; Dasgupta S; da Silva LM; Rocconi RP; Carter JE; Singh S; Singh AP
Sci Rep; 2021 Jun; 11(1):12901. PubMed ID: 34145334
[TBL] [Abstract] [Full Text] [Related]
3. The functional consequences and prognostic value of dosage sensitivity in ovarian cancer.
Yan Z; Liu Y; Wei Y; Zhao N; Zhang Q; Wu C; Chang Z; Xu Y
Mol Biosyst; 2017 Jan; 13(2):380-391. PubMed ID: 28067383
[TBL] [Abstract] [Full Text] [Related]
4. [Primary fallopian tube carcinoma].
Mladenović-Segedi L
Med Pregl; 2009; 62(1-2):31-6. PubMed ID: 19514598
[TBL] [Abstract] [Full Text] [Related]
5. Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Sabbatini P; Dupont J; Aghajanian C; Derosa F; Poynor E; Anderson S; Hensley M; Livingston P; Iasonos A; Spriggs D; McGuire W; Reinartz S; Schneider S; Grande C; Lele S; Rodabaugh K; Kepner J; Ferrone S; Odunsi K
Clin Cancer Res; 2006 Sep; 12(18):5503-10. PubMed ID: 17000686
[TBL] [Abstract] [Full Text] [Related]
6. Changes in tumorigenesis- and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays.
Martoglio AM; Tom BD; Starkey M; Corps AN; Charnock-Jones DS; Smith SK
Mol Med; 2000 Sep; 6(9):750-65. PubMed ID: 11071270
[TBL] [Abstract] [Full Text] [Related]